Authors
Loading...
In vitro study demonstrates IL-2 and IL-5 reduce repressor binding at the J-chain promoter in lymphoma B cells, suggesting convergent signaling drives IgM joining component expression.
McFadden et al. (1991) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: